{"groups":[{"description":"Patients receive G-CSF SC QD on days 1-4.\n\nfilgrastim: Given SC","id":"FG000","title":"Arm I: Control"},{"description":"Patients receive G-CSF SC QD on days 1-4 and plerixafor SC QD on days 4-8.\n\nplerixafor: Given SC\n\nfilgrastim: Given SC","id":"FG001","title":"Arm II: Experimental"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"4"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"4"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}